Additionally, mitochondrial dysfunction in spermmanifested as decreased mitochondrial MMPimpairs energy metabolism and reduces motility [9, 11]
Results announced in September 2025 and published in The Lancet in February 2026 demonstrated orforglipron's superiority over oral semaglutide on both HbA1c reduction (approximately 2.2 vs 1.4 percentage points) and weight loss (approximately 9.2% vs 5.3%)
Naunyn Schmiedebergs Arch Pharmacol 397(5):33013312 Zhou Q, He DX, Deng YL, Wang CL, Zhang LL, Jiang FM et al (2022) MiR-124-3p targeting PDE4B attenuates LPS-induced ALI through the TLR4/NF-B signaling pathway
396 EXP CELL RES
Trulicity (dulaglutide) injection, for subcutaneous use prescribing information
Mounjaro Vision Loss Lawsuit : A landmark study published in 2024 examined medical records from a large ophthalmology practice, revealing statistically significant increases in NAION incidence among patients prescribed these medications for type 2 diabetes and obesity management